Research
OCRA invests more funds into ovarian cancer research than any other public charity.
Read more about Research Read about groundbreaking OCRA-funded research
OCRA's Mission & Impact
Mission & Impact
Our Mission Statement: Ovarian Cancer Research Alliance is dedicated to curing ovarian cancer while improving treatments by advancing innovative science, promoting preventive measures, and advocating for, educating and supporting anyone affected by gynecologic cancers to ensure the best possible care and outcomes.
Results and Milestones
Numbers tell the story of our impact
- Research and Education Funding
- OCRA’s advocacy efforts have helped secure more than $4.4 billion in federal research and education funding
- $4.4B
- Invested in Science Innovation
- $150M raised and invested in scientific breakthroughs
- $150M
- Individuals Helped Each Year
- Our programs support more than 140,000 individuals annually
- 140K
For each dollar we spend, 82 cents goes to funding critical research and innovative programs
Advancing Research and Fueling Hope
OCRA has both a laser focus and a panoramic view when it comes to the fight against gynecologic cancers.
Center for Public Policy
OCRA has built a team of passionate, dedicated advocates.
Read more about Center for Public Policy Discover our advocacy impact and get involved
Patient Support
In times of adversity, support becomes a beacon of hope.
Read more about Patient Support Learn about our unique programs
OCRA's History of Impact and Innovation
Ovarian Cancer Research Alliance (OCRA) is the oldest and largest ovarian and gynecologic cancer charity in the world. Since its founding in 1994, OCRA has grown into the leading non-government funder of ovarian and related gynecologic cancer research, investing over $150 million in groundbreaking studies. Through innovative education and advocacy efforts, compassionate support programs, and cross-industry collaboration, OCRA is driving progress and pushing the boundaries of what’s possible to improve outcomes for patients and advance research in its quest for a cure.
Related Topics
OCRA Sponsors NCCN Guidelines for Cervical, Ovarian, and Uterine Cancer Patients
This article was updated in October 2026 to reflect NCCN’s release of the 2026 Guidelines for Ovarian Cancer Patients. OCRA is a proud sponsor of the 2026 Patient Guidelines for Ovarian Cancer, Cervical Cancer, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful guides for anyone newly diagnosed … Continued
OCRA’s Rivkin Ovarian Cancer Research Symposium Convenes A Scientific Community Ready to Accelerate Progress
Researchers, clinicians, and advocates gather to share findings and build collaborations More than 375 researchers, clinicians, and advocates from across the ovarian cancer community gathered in Philadelphia for the 16th Biennial Rivkin Ovarian Cancer Research Symposium, presented for the first time by Ovarian Cancer Research Alliance (OCRA), from October 16-18. Founded in 1996 by the … Continued
“Nobody Wants This” Star Jackie Tohn Plays for OCRA on Who Wants To Be A Millionaire
Actress and comedian Jackie Tohn, known for playing Esther Roklov on Netflix’s Nobody Wants This, and a fan favorite from American Idol and GLOW, stepped into the hot seat on Who Wants To Be A Millionaire hosted by Jimmy Kimmel to play on behalf of Ovarian Cancer Research Alliance (OCRA), ultimately winning $125,000 to support … Continued